Researchers approximate that 387 million people worldwide are living with diabetes mellitus, whose prevalence will reach 10% of the world’s adult population (592 million) by 2035.

In this week's Homerun Slides, the effectiveness of Lixisenatide when added to basal insulin, and strategies for avoiding or minimizing the GI effects of GLP-1.

Each week we try to bring you the latest in diabetes care, and some of you often email me about the Homerun Slides and how they often explore therapies with drugs that are not available to use in practice. This week’s Slides look at studies using a yet-to-be-approved GLP-1 analog …